A Single-center, Open-label Positron Emission Tomography Study to Evaluate the Time-course of Displacement of [11C]UCB-J by Brivaracetam and Levetiracetam in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2017
At a glance
- Drugs Brivaracetam (Primary) ; Levetiracetam (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- Sponsors UCB
- 27 Oct 2017 Status changed from recruiting to completed.
- 11 May 2017 Status changed from completed to recruiting.
- 28 Apr 2017 Results comparing the entrance rate of brivaracetam with levetiracetam presented at the 69th Annual Meeting of the American Academy of Neurology.